Document ID: chunk:federal_register_of_legislation:F2025C00126:schedule:1:p12
Version: federal_register_of_legislation:F2025C00126
Segment Type: schedule
Provision Reference: sch 1 (pt 12/23)
Character Range: 79604–86534

10 mg, 60                                                                                                      Oral                        Ikotab                                              (a) between 1 July 2023 and 31 December 2023—0 months stock by reference to usual demand
                                                                                                                                                                                                                                                                                           (b) after 31 December 2023—2 months stock by reference to usual demand
Nicorandil                                                                          Tablets 20 mg, 60                                                                                                      Oral                        APO‑Nicorandil                                      2 months stock by reference to usual demand
Nicorandil                                                                          Tablets 20 mg, 60                                                                                                      Oral                        Ikotab                                              (a) between 1 July 2023 and 31 December 2023—0 months stock by reference to usual demand
                                                                                                                                                                                                                                                                                           (b) after 31 December 2023—2 months stock by reference to usual demand
Norfloxacin                                                                         Tablet 400 mg                                                                                                          Oral                        APO‑Norfloxacin                                     2.5 months stock by reference to usual demand
Olanzapine                                                                          Tablet 10 mg                                                                                                           Oral                        APO-OLANZAPINE                                      4 months stock by reference to usual demand of both Olanzapine APOTEX and APO-OLANZAPINE added together
Olanzapine                                                                          Tablet 10 mg (orally disintegrating)                                                                                   Oral                        Zypine ODT                                          (a) between 1 February 2024 and 30 September 2024—4 months stock by reference to usual demand of the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 10 mg, Oral;
                                                                                                                                                                                                                                                                                           (b) between 1 October 2024 and 31 March 2025—4 months stock by reference to usual demand of both the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 10 mg, Oral and the brand Zypine ODT of the pharmaceutical item Olanzapine, Tablet 10 mg (orally disintegrating), Oral, added together
Olanzapine                                                                          Tablet 15 mg (orally disintegrating)                                                                                   Oral                        PRYZEX ODT                                          (a) between 1 July 2023 and 31 December 2023—3 months stock by reference to usual demand
                                                                                                                                                                                                                                                                                           (b) after 31 December 2023—3.5 months stock by reference to usual demand
Olanzapine                                                                          Tablet 15 mg (orally disintegrating)                                                                                   Oral                        Zypine ODT                                          (a) between 1 February 2024 and 30 September 2024—4 months stock by reference to usual demand of the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 15 mg, Oral;
                                                                                                                                                                                                                                                                                           (b) between 1 October 2024 and 31 March 2025—4 months stock by reference to usual demand of both the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 15 mg, Oral and the brand Zypine ODT of the pharmaceutical item Olanzapine, Tablet 15 mg (orally disintegrating), Oral, added together.
Olanzapine                                                                          Tablet 2.5 mg                                                                                                          Oral                        APO-OLANZAPINE                                      6 months stock by reference to usual demand of both Olanzapine APOTEX and APO-OLANZAPINE added together
Olanzapine                                                                          Tablet 20 mg (orally disintegrating)                                                                                   Oral                        Zypine ODT                                          (a) between 1 February 2024 and 30 September 2024—4 months stock by reference to usual demand of the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 20 mg, Oral;
                                                                                                                                                                                                                                                                                           (b) between 1 October 2024 and 31 March 2025—4 months stock by reference to usual demand of both the brand Zypine ODT of the pharmaceutical item Olanzapine, Wafer 20 mg, Oral and the brand Zypine ODT of the pharmaceutical item Olanzapine, Tablet 20 mg (orally disintegrating), Oral, added together
Olanzapine                                                                          Tablet 5 mg                                                                                                            Oral                        APO-OLANZAPINE                                      4 months